Epidemiology of preterm birth and neonatal outcome

Shi Wu Wen1, Graeme Smith, Qiuying Yang

  • 1OMNI Research Group, Department of Obstetrics & Gynecology, University of Ottawa, Ontario, Canada. swwen@ohri.ca

Insights

Preterm birth rates are rising, causing significant infant mortality and morbidity. While survival has improved, research must focus on reducing long-term complications and understanding preterm birth causes.

Area of Science:

  • Neonatalogy
  • Public Health
  • Developmental Pediatrics

Background:

  • Prevalence of preterm birth (<37 weeks' gestation) is increasing globally, affecting 5-11% of infants in industrialized nations.
  • Preterm births are a leading cause of neonatal mortality (70%) and morbidity (75%), leading to long-term neurodevelopmental, pulmonary, and ophthalmologic issues.
  • Advances in neonatal care, like antenatal corticosteroids and surfactant therapy, have improved survival but not reduced preterm birth incidence, incurring substantial healthcare costs.

Purpose of the Study:

  • To highlight the increasing trend and severe consequences of preterm birth.
  • To emphasize the need for research focused on preventing preterm births and mitigating long-term sequelae in survivors.
  • To underscore the economic burden associated with caring for premature infants with complex health needs.

Main Methods:

  • This abstract reviews existing data on preterm birth rates, mortality, morbidity, and associated healthcare costs.
  • It synthesizes information on current interventions and their impact on survival versus prevention.
  • It identifies key areas for future research based on current challenges and outcomes.

Main Results:

  • Despite improved survival rates for extremely premature infants due to medical interventions, the incidence of preterm birth continues to rise.
  • Current interventions primarily manage complications rather than prevent preterm birth itself.
  • Significant societal and healthcare costs persist for the care of survivors with severe morbidities and developmental challenges.

Conclusions:

  • Future research priorities should include elucidating the etiology and mechanisms of preterm birth.
  • Focus is needed on developing strategies to reduce long-term health sequelae and developmental handicaps in preterm infants.
  • A shift towards prevention and long-term outcome improvement is crucial for addressing the preterm birth crisis.

Related Concept Videos

Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...